Photochemotherapy agent

This page covers all Photochemotherapy agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA (non-specific cross-linking).

Targets

DNA (non-specific cross-linking)

Marketed (2)

• Methoxsalen+ECP · M.D. Anderson Cancer Center · Oncology
  Methoxsalen combined with extracorporeal photochemotherapy (ECP) uses a photosensitizing agent activated by ultraviolet A light to induce apoptosis in circulating malignant T cells.
• PUVA (8-MOP + UVA) · Madrilenian Group of Cutaneous Lymphomas · Oncology
  PUVA therapy uses 8-methoxypsoralen (8-MOP) as a photosensitizing agent combined with UVA radiation to induce apoptosis in malignant T cells and suppress immune-mediated skin inflammation.